10.2.2 Skeletal muscle relaxants
Baclofen
Baclofen 10mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Gamma-butyrolactone (GBL) withdrawal and dependence |
| Central nervous system | Increased muscle tone (spasticity and dystonia) |
Baclofen 10mg/5ml solution for infusion ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Increased muscle tone (spasticity and dystonia) |
Baclofen 15mg/5ml solution for injection ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Increased muscle tone (spasticity and dystonia) |
Baclofen 40mg/20ml solution for infusion ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Increased muscle tone (spasticity and dystonia) |
Baclofen 5mg/5ml oral solution sugar free
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Increased muscle tone (spasticity and dystonia) |
Dantrolene
Dantrolene 100mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Increased muscle tone (spasticity and dystonia) |
Dantrolene 25mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Increased muscle tone (spasticity and dystonia) |
Diazepam
Diazepam 2mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Increased muscle tone (spasticity and dystonia) |
Diazepam 2mg/5ml oral solution sugar free
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Increased muscle tone (spasticity and dystonia) |
Diazepam 5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Increased muscle tone (spasticity and dystonia) |
Dronabinol + Cannabidiol
Sativex oromucosal spray
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Increased muscle tone (spasticity and dystonia) |
Tizanidine
Tizanidine 2mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Increased muscle tone (spasticity and dystonia) |
Tizanidine 4mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Increased muscle tone (spasticity and dystonia) |